LBP-045 Efficacy and safety of HSK31679, a thyroid hormone receptor β agonist, for the treatment of asian non-alcoholic fatty liver disease: a multicenter randomized, double-blind, placebo-controlled, phase 2a trial
| Autor: | Xue, Feng, Ma, Wei, Gao, Jixian, Chen, Jinjun, Yue, Wei, Bu, Peili, Chen, Qincong, Chen, Hao, Sheng, Jianlong, Chen, Liang, Liu, Fei, Zhu, Chuanwu, Zhong, Bihui, Li, Guang-Ming, Zhang, Jianming, Wang, Le, Cai, Qingxian, Pei, Zhaohui, Chen, Ying, Yao, Lvfeng, Lv, Lingchun, Gao, Yanhang, Xia, Bihua, Ji, Xianyou, Liu, Yang, Du, Laijing, Ma, Genshan, Hao, Kunyan, Huo, Yong, Wei, Lai |
|---|---|
| Zdroj: | In Journal of Hepatology June 2024 80 Supplement 1:S100-S101 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect